Sexual Dysfunction

News of Note

FDA Approves a Hormonal Injection for Low Libido in Women

Topics: Addyi | Female hypoactive sexual desire disorder | Female Issues in Psychiatry | Low libido | Sexual Dysfunction | Vyleesi | Women’s Issues in Psychiatry

On June 24, 2019, the FDA approved Vyleesi (bremelanotide injection) for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. Bremelanotide is an analogue of the α-melanocyte-stimulating hormone, which activates melanocortin in the nervous system. This hormone was originally explored as a sunless tanning agent in the 1980s.

Read More
Article

Sexual Side Effects of the Newer Antidepressants

Topics: Practice Tools and Tips | Psychopharmacology Tips | Sexual Dysfunction

It’s no secret that SSRIs and SNRIs cause sexual dysfunction (SD) in a large proportion of patients who take them. The exact size of that proportion, though, is difficult to pinpoint with any reliability. Most of the large clinical trials of antidepressants ascertain side effects through spontaneous reports, and research subjects are understandably em

Read More